The global market for Intravitreal Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.

North American market for Intravitreal Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravitreal Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Intravitreal Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Qilu Pharmaceutical Co.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravitreal Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injection.

The Intravitreal Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravitreal Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravitreal Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravitreal Injection Market Report

Report Metric	Details
Report Name	Intravitreal Injection Market
Segment by Type	Ranibizumab Bevacizumab Aflibercept Brolucizumab Faricimab Others
Segment by Application	Diabetic Eye Disease AMD Retinal Vein Occlusion Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Qilu Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intravitreal Injection Market report?

Ans: The main players in the Intravitreal Injection Market are Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio, Regeneron, Roche, Qilu Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group

What are the Application segmentation covered in the Intravitreal Injection Market report?

Ans: The Applications covered in the Intravitreal Injection Market report are Diabetic Eye Disease, AMD, Retinal Vein Occlusion, Others

What are the Type segmentation covered in the Intravitreal Injection Market report?

Ans: The Types covered in the Intravitreal Injection Market report are Ranibizumab, Bevacizumab, Aflibercept, Brolucizumab, Faricimab, Others

1 Intravitreal Injection Market Overview

1.1 Product Definition

1.2 Intravitreal Injection by Type

1.2.1 Global Intravitreal Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 Ranibizumab

1.2.3 Bevacizumab

1.2.4 Aflibercept

1.2.5 Brolucizumab

1.2.6 Faricimab

1.2.7 Others

1.3 Intravitreal Injection by Application

1.3.1 Global Intravitreal Injection Market Value by Application (2024 VS 2031)

1.3.2 Diabetic Eye Disease

1.3.3 AMD

1.3.4 Retinal Vein Occlusion

1.3.5 Others

1.4 Global Intravitreal Injection Market Size Estimates and Forecasts

1.4.1 Global Intravitreal Injection Revenue 2020-2031

1.4.2 Global Intravitreal Injection Sales 2020-2031

1.4.3 Global Intravitreal Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Intravitreal Injection Market Competition by Manufacturers

2.1 Global Intravitreal Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Intravitreal Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Intravitreal Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Intravitreal Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Intravitreal Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Intravitreal Injection, Product Type & Application

2.7 Global Key Manufacturers of Intravitreal Injection, Date of Enter into This Industry

2.8 Global Intravitreal Injection Market Competitive Situation and Trends

2.8.1 Global Intravitreal Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Intravitreal Injection Players Market Share by Revenue

2.8.3 Global Intravitreal Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Intravitreal Injection Market Scenario by Region

3.1 Global Intravitreal Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Intravitreal Injection Sales by Region: 2020-2031

3.2.1 Global Intravitreal Injection Sales by Region: 2020-2025

3.2.2 Global Intravitreal Injection Sales by Region: 2026-2031

3.3 Global Intravitreal Injection Revenue by Region: 2020-2031

3.3.1 Global Intravitreal Injection Revenue by Region: 2020-2025

3.3.2 Global Intravitreal Injection Revenue by Region: 2026-2031

3.4 North America Intravitreal Injection Market Facts & Figures by Country

3.4.1 North America Intravitreal Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Intravitreal Injection Sales by Country (2020-2031)

3.4.3 North America Intravitreal Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Intravitreal Injection Market Facts & Figures by Country

3.5.1 Europe Intravitreal Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Intravitreal Injection Sales by Country (2020-2031)

3.5.3 Europe Intravitreal Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Intravitreal Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Intravitreal Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Intravitreal Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Intravitreal Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Intravitreal Injection Market Facts & Figures by Country

3.7.1 Latin America Intravitreal Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Intravitreal Injection Sales by Country (2020-2031)

3.7.3 Latin America Intravitreal Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Intravitreal Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Intravitreal Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Intravitreal Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Intravitreal Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Intravitreal Injection Sales by Type (2020-2031)

4.1.1 Global Intravitreal Injection Sales by Type (2020-2025)

4.1.2 Global Intravitreal Injection Sales by Type (2026-2031)

4.1.3 Global Intravitreal Injection Sales Market Share by Type (2020-2031)

4.2 Global Intravitreal Injection Revenue by Type (2020-2031)

4.2.1 Global Intravitreal Injection Revenue by Type (2020-2025)

4.2.2 Global Intravitreal Injection Revenue by Type (2026-2031)

4.2.3 Global Intravitreal Injection Revenue Market Share by Type (2020-2031)

4.3 Global Intravitreal Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Intravitreal Injection Sales by Application (2020-2031)

5.1.1 Global Intravitreal Injection Sales by Application (2020-2025)

5.1.2 Global Intravitreal Injection Sales by Application (2026-2031)

5.1.3 Global Intravitreal Injection Sales Market Share by Application (2020-2031)

5.2 Global Intravitreal Injection Revenue by Application (2020-2031)

5.2.1 Global Intravitreal Injection Revenue by Application (2020-2025)

5.2.2 Global Intravitreal Injection Revenue by Application (2026-2031)

5.2.3 Global Intravitreal Injection Revenue Market Share by Application (2020-2031)

5.3 Global Intravitreal Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Intravitreal Injection Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis Intravitreal Injection Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Bayer

6.3.1 Bayer Company Information

6.3.2 Bayer Description and Business Overview

6.3.3 Bayer Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bayer Intravitreal Injection Product Portfolio

6.3.5 Bayer Recent Developments/Updates

6.4 Genentech

6.4.1 Genentech Company Information

6.4.2 Genentech Description and Business Overview

6.4.3 Genentech Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Genentech Intravitreal Injection Product Portfolio

6.4.5 Genentech Recent Developments/Updates

6.5 Apellis Pharmaceuticals, Inc.

6.5.1 Apellis Pharmaceuticals, Inc. Company Information

6.5.2 Apellis Pharmaceuticals, Inc. Description and Business Overview

6.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolio

6.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates

6.6 Coherus BioSciences Inc.

6.6.1 Coherus BioSciences Inc. Company Information

6.6.2 Coherus BioSciences Inc. Description and Business Overview

6.6.3 Coherus BioSciences Inc. Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Coherus BioSciences Inc. Intravitreal Injection Product Portfolio

6.6.5 Coherus BioSciences Inc. Recent Developments/Updates

6.7 Iveric Bio

6.7.1 Iveric Bio Company Information

6.7.2 Iveric Bio Description and Business Overview

6.7.3 Iveric Bio Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Iveric Bio Intravitreal Injection Product Portfolio

6.7.5 Iveric Bio Recent Developments/Updates

6.8 Regeneron

6.8.1 Regeneron Company Information

6.8.2 Regeneron Description and Business Overview

6.8.3 Regeneron Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Regeneron Intravitreal Injection Product Portfolio

6.8.5 Regeneron Recent Developments/Updates

6.9 Roche

6.9.1 Roche Company Information

6.9.2 Roche Description and Business Overview

6.9.3 Roche Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Roche Intravitreal Injection Product Portfolio

6.9.5 Roche Recent Developments/Updates

6.10 Qilu Pharmaceutical Co.,Ltd.

6.10.1 Qilu Pharmaceutical Co.,Ltd. Company Information

6.10.2 Qilu Pharmaceutical Co.,Ltd. Description and Business Overview

6.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolio

6.10.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates

6.11 Chengdu Kanghong Pharmaceutical Group

6.11.1 Chengdu Kanghong Pharmaceutical Group Company Information

6.11.2 Chengdu Kanghong Pharmaceutical Group Description and Business Overview

6.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolio

6.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Intravitreal Injection Industry Chain Analysis

7.2 Intravitreal Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Intravitreal Injection Production Mode & Process Analysis

7.4 Intravitreal Injection Sales and Marketing

7.4.1 Intravitreal Injection Sales Channels

7.4.2 Intravitreal Injection Distributors

7.5 Intravitreal Injection Customer Analysis

8 Intravitreal Injection Market Dynamics

8.1 Intravitreal Injection Industry Trends

8.2 Intravitreal Injection Market Drivers

8.3 Intravitreal Injection Market Challenges

8.4 Intravitreal Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Genentech Inc

Apellis Pharmaceuticals Inc

IVERIC bio

Regeneron

Qilu Pharmaceutical Co. Ltd.

Chengdu Kanghong Pharmaceutical Group

List of Tables

Table 1. Global Intravitreal Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Intravitreal Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Intravitreal Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Intravitreal Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Intravitreal Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Intravitreal Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Intravitreal Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Intravitreal Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Intravitreal Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Intravitreal Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Intravitreal Injection, Product Type & Application

Table 12. Global Key Manufacturers of Intravitreal Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Intravitreal Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Intravitreal Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Intravitreal Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Intravitreal Injection Sales Market Share by Region (2020-2025)

Table 19. Global Intravitreal Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Intravitreal Injection Sales Market Share by Region (2026-2031)

Table 21. Global Intravitreal Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Intravitreal Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Intravitreal Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Intravitreal Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Intravitreal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Intravitreal Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Intravitreal Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Intravitreal Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Intravitreal Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Intravitreal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Intravitreal Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Intravitreal Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Intravitreal Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Intravitreal Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Intravitreal Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Intravitreal Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Intravitreal Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Intravitreal Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Intravitreal Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravitreal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Intravitreal Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Intravitreal Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Intravitreal Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Intravitreal Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Intravitreal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Intravitreal Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Intravitreal Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Intravitreal Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Intravitreal Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Intravitreal Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Intravitreal Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Intravitreal Injection Sales Market Share by Type (2020-2025)

Table 53. Global Intravitreal Injection Sales Market Share by Type (2026-2031)

Table 54. Global Intravitreal Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Intravitreal Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Intravitreal Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Intravitreal Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Intravitreal Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Intravitreal Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Intravitreal Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Intravitreal Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Intravitreal Injection Sales Market Share by Application (2020-2025)

Table 63. Global Intravitreal Injection Sales Market Share by Application (2026-2031)

Table 64. Global Intravitreal Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Intravitreal Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Intravitreal Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Intravitreal Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Intravitreal Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Intravitreal Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi Intravitreal Injection Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Novartis Intravitreal Injection Product

Table 79. Novartis Recent Developments/Updates

Table 80. Bayer Company Information

Table 81. Bayer Description and Business Overview

Table 82. Bayer Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Bayer Intravitreal Injection Product

Table 84. Bayer Recent Developments/Updates

Table 85. Genentech Company Information

Table 86. Genentech Description and Business Overview

Table 87. Genentech Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Genentech Intravitreal Injection Product

Table 89. Genentech Recent Developments/Updates

Table 90. Apellis Pharmaceuticals, Inc. Company Information

Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview

Table 92. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product

Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates

Table 95. Coherus BioSciences Inc. Company Information

Table 96. Coherus BioSciences Inc. Description and Business Overview

Table 97. Coherus BioSciences Inc. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Coherus BioSciences Inc. Intravitreal Injection Product

Table 99. Coherus BioSciences Inc. Recent Developments/Updates

Table 100. Iveric Bio Company Information

Table 101. Iveric Bio Description and Business Overview

Table 102. Iveric Bio Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Iveric Bio Intravitreal Injection Product

Table 104. Iveric Bio Recent Developments/Updates

Table 105. Regeneron Company Information

Table 106. Regeneron Description and Business Overview

Table 107. Regeneron Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Regeneron Intravitreal Injection Product

Table 109. Regeneron Recent Developments/Updates

Table 110. Roche Company Information

Table 111. Roche Description and Business Overview

Table 112. Roche Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Roche Intravitreal Injection Product

Table 114. Roche Recent Developments/Updates

Table 115. Qilu Pharmaceutical Co.,Ltd. Company Information

Table 116. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview

Table 117. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product

Table 119. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates

Table 120. Chengdu Kanghong Pharmaceutical Group Company Information

Table 121. Chengdu Kanghong Pharmaceutical Group Description and Business Overview

Table 122. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product

Table 124. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Intravitreal Injection Distributors List

Table 128. Intravitreal Injection Customers List

Table 129. Intravitreal Injection Market Trends

Table 130. Intravitreal Injection Market Drivers

Table 131. Intravitreal Injection Market Challenges

Table 132. Intravitreal Injection Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Intravitreal Injection

Figure 2. Global Intravitreal Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravitreal Injection Market Share by Type: 2024 & 2031

Figure 4. Ranibizumab Product Picture

Figure 5. Bevacizumab Product Picture

Figure 6. Aflibercept Product Picture

Figure 7. Brolucizumab Product Picture

Figure 8. Faricimab Product Picture

Figure 9. Others Product Picture

Figure 10. Global Intravitreal Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Intravitreal Injection Market Share by Application: 2024 & 2031

Figure 12. Diabetic Eye Disease

Figure 13. AMD

Figure 14. Retinal Vein Occlusion

Figure 15. Others

Figure 16. Global Intravitreal Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Intravitreal Injection Market Size (2020-2031) & (US$ Million)

Figure 18. Global Intravitreal Injection Sales (2020-2031) & (K Units)

Figure 19. Global Intravitreal Injection Average Price (US$/Unit) & (2020-2031)

Figure 20. Intravitreal Injection Report Years Considered

Figure 21. Intravitreal Injection Sales Share by Manufacturers in 2024

Figure 22. Global Intravitreal Injection Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Intravitreal Injection Players: Market Share by Revenue in Intravitreal Injection in 2024

Figure 24. Intravitreal Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Intravitreal Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Intravitreal Injection Sales Market Share by Country (2020-2031)

Figure 27. North America Intravitreal Injection Revenue Market Share by Country (2020-2031)

Figure 28. United States Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Intravitreal Injection Sales Market Share by Country (2020-2031)

Figure 31. Europe Intravitreal Injection Revenue Market Share by Country (2020-2031)

Figure 32. Germany Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Intravitreal Injection Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Intravitreal Injection Revenue Market Share by Region (2020-2031)

Figure 39. China Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Intravitreal Injection Sales Market Share by Country (2020-2031)

Figure 47. Latin America Intravitreal Injection Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Intravitreal Injection Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Intravitreal Injection Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Intravitreal Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Intravitreal Injection by Type (2020-2031)

Figure 57. Global Revenue Market Share of Intravitreal Injection by Type (2020-2031)

Figure 58. Global Intravitreal Injection Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Intravitreal Injection by Application (2020-2031)

Figure 60. Global Revenue Market Share of Intravitreal Injection by Application (2020-2031)

Figure 61. Global Intravitreal Injection Price (US$/Unit) by Application (2020-2031)

Figure 62. Intravitreal Injection Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Intravitreal IVT Injectables Market Insights Forecast to 2030

Global Intravitreal Injection of Anti VEGF Drugs Market Research Report 2024

Global Robotic Intravitreal Injection System Market Research Report 2024

Global Intraocular Injections Market Research Report 2024

Global Anti VEGF Intravitreal Drugs Market Research Report 2024

Global Intravitreal Implant Market Research Report 2024

Global Implantable Ophthalmic Drugs Market Research Report 2025

Global Ranibizumab Injection Market Research Report 2024

Global Vitrectomy Surgery System Market Research Report 2024

Global Monoclonal Antibody Anti VEGF Ophthalmic Drugs Market Research Report 2024

Global Avastin Bevacizumab Biosimilars Market Research Report 2024

Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fluocinolone Acetonide Intravitreal Implant Market Research Report 2024

Global Eye Injection Market Research Report 2024

Global Retinal Vasculitis Treatment Market Research Report 2025

Global Vitreoretinal Surgery Device Market Research Report 2025

Global Fully Preloaded IOL Injector Market Research Report 2024

Global Vitrectomy Cutters Market Research Report 2024

Global Vitreo Retinal Prefilled Silicone Oil Syringe Market Insights Forecast to 2030

RELATED REPORTS

Global Single-Port Vitrectomy Cutter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13L12609

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Eye Ultrasound Biomicroscope Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32B20021

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Plano-Convex Laser Lenses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38C19846

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Heated Eye Masks Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2H20253

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions